Mitsubishi UFJ Asset Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-32,961
Closed -$1.37M 1549
2023
Q2
$1.37M Buy
32,961
+131
+0.4% +$8.13K ﹤0.01% 790
2023
Q1
$1.97M Buy
32,830
+4,850
+17% +$388K ﹤0.01% 734
2022
Q4
$1.9M Buy
27,980
+43
+0.2% +$3.23K 0.01% 726
2022
Q3
$2.12M Buy
27,937
+4,803
+21% +$375K 0.01% 693
2022
Q2
$1.61M Hold
23,134
0.01% 744
2022
Q1
$1.92M Sell
23,134
-510
-2% -$37.6K 0.01% 745
2021
Q4
$1.89M Buy
23,644
+1,376
+6% +$138K 0.01% 766
2021
Q3
$2.59M Buy
22,268
+2,280
+11% +$345K 0.01% 697
2021
Q2
$4.43M Buy
19,988
+1,395
+8% +$271K 0.02% 589
2021
Q1
$2.46M Buy
18,593
+2,447
+15% +$387K 0.02% 656
2020
Q4
$2.79M Sell
16,146
-7,154
-31% -$979K 0.02% 580
2020
Q3
$2.59M Sell
23,300
-15,300
-40% -$1.22M 0.02% 526
2020
Q2
$2.29M Buy
38,600
+6,500
+20% +$427K 0.03% 503
2020
Q1
$2.16M Buy
32,100
+12,900
+67% +$1.02M 0.03% 437
2019
Q4
$1.44M Buy
19,200
+12,800
+200% +$1.03M 0.02% 625
2019
Q3
$479K Buy
+6,400
New +$512K 0.01% 745
2018
Q4
Sell
-2,929
Closed -$153K 933
2018
Q3
$153K Sell
2,929
-307
-9% -$12.2K ﹤0.01% 801
2018
Q2
$101K Sell
3,236
-299
-8% -$8.32K ﹤0.01% 798
2018
Q1
$77K Buy
+3,535
New +$76K ﹤0.01% 808

Other funds holding NVCR

Mitsubishi UFJ Asset Management's NVCR Position: Q3 2023 in Review

Mitsubishi UFJ Asset Management sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 32,961 shares — an estimated $1.37M sold.

Mitsubishi UFJ Asset Management first reported a position in NVCR in Q1 2018 and held it in 19 quarters. The position peaked at $4.43M in Q2 2021. 226 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.

  • Mitsubishi UFJ Asset Management reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 32,961 NovoCure shares in Q3 2023, an estimated $1.37M.
  • Mitsubishi UFJ Asset Management first reported a position in NovoCure in Q1 2018 and held it in 19 quarters.
  • Mitsubishi UFJ Asset Management's NovoCure position peaked at $4.43M in Q2 2021.
  • 226 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q3 2023, filed 7 Nov 2023.